Mature blood cells are derived from a small number of primitive pluripotent stem cells that generate progenitor cells committed to one or a few hematopoietic lineages. Hematopoietic cell survival, proliferation, and differentiation are controlled through the interaction of specific growth factors with their cognate receptors differentially expressed on the surface of progenitor and mature hematopoietic cells. Genetic alterations subverting this control network may lead to the development of leukemia (for reviews, see references 7 and 8).
In vivo experiments with recombinant retroviruses carrying growth factor genes have been performed to investigate the role of growth factors in leukemogenesis. The overexpression of growth factors, such as granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin-3 (IL-3), or erythropoietin, resulted in the massive proliferation of hematopoietic precursors but did not cause overt leukemias (4, 18, 25, 39, 55) while the overexpression of IL-6 led to transplantable myeloproliferative or lymphoproliferative disorders (14) . There is some evidence that abnormal expression of growth factor receptors may also be involved in leukemogenesis. Up-regulated expression of cytokine receptors caused by the insertion of a viral element in the vicinity of a receptor gene has been reported in murine hematopoietic cell lines, such as the IL-2 receptor and the prolactin receptor in T-cell lymphomas (1, 22) , the IL-6 receptor in a plasmacytoma line (48) , and the erythropoietin receptor in erythroleukemias (16, 24) .
The c-fms proto-oncogene encodes the M-CSF receptor (M-CSFR), a member of the tyrosine kinase class of growth factor receptors, expressed in differentiated cells of the myelomonocytic lineage (41) . This gene has been implicated in myeloid leukemias induced by the replication-competent helper Friend murine leukemia virus (F-MuLV) (12) . Several months after inoculation of mice of different strains, F-MuLV induces clonal leukemias of different types: lymphoblastic, erythroblastic, myeloblastic, and mixed leukemias. The relative frequencies of these diseases are affected by the age at inoculation, as well as the mouse and F-MuLV strain (5, 42, 54) . Furthermore, depending on the type of leukemia, F-MuLV proviruses are found integrated in common regions of the host cellular DNA and activate the expression of different cellular genes (reviewed in reference 50). We have previously shown that in myeloblastic leukemias, proviral integration at the 5Ј end of the murine c-fms proto-oncogene locus enhanced the expression of a normal c-fms transcript (9, 12) . Since murine myeloblastic leukemic cells also express the M-CSF gene (unpublished results), an autocrine loop could participate in the leukemic process in these cells.
We wondered whether overexpression of the c-fms gene in the context of F-MuLV-induced leukemia would accelerate the appearance of the disease. To answer this question, we constructed a murine retrovirus containing the murine c-fms cDNA, which was pseudotyped with F-MuLV as the helper virus and inoculated into newborn DBA/2 mice. We show here that the viral complex (c-fms-containing virus and helper virus) induces the same types of leukemia as those of F-MuLV alone, with a much shorter latency (50% disease incidence; 165 days versus 358 days after inoculation). Furthermore, analysis of integrated c-fms proviruses indicated that they frequently underwent in vivo rearrangements. Viruses isolated from tumors with rearranged proviruses presented large deletions in the extracellular domain of the M-CSFR but did not contain additional helper-derived sequences. We showed that viruses carrying truncated forms of the c-fms gene were able to transform NIH 3T3 cells and that such truncations most likely produce constitutively activated forms of the receptor.
MATERIALS AND METHODS
Generation of the c-fms-containing retroviral vector. The retroviral vector HF was derived from the Harvey sarcoma virus which carries the Ha-ras oncogene flanked by rat retrovirus-like sequences (VL30). The p21 ras oncogene was removed, and the 3Ј Moloney long terminal repeat was replaced with a long terminal repeat isolated from the FB29 F-MuLV strain (44, 46) . The F6 c-fms clone has been previously described (9) . A 3-kb EcoRI-NdeI fragment containing the entire c-fms open reading frame was treated with Klenow enzyme and introduced through SalI linkers into the unique SalI cloning site of the HF vector. The resulting plasmid containing the c-fms cDNA was called pHFfms.
Production of virus and titration of virus stocks. NIH 3T3 cells (3 ϫ 10 5 ) were cotransfected with 250 ng of linearized pHFfms and 25 ng of pAG60 which contains the neomycin resistance gene. After G418 selection (1 mg/ml), cells isolated from a highly transformed focus were superinfected with clone 57 of F-MuLV (29) (1 focus-forming unit [FFU] for 100 cells). The transforming virus containing c-fms, designated HFfms, was titrated on NIH 3T3 cells. A total of 5 ϫ 10 4 cells were infected with 10-fold serial viral dilutions, and 5 to 7 days postinfection, foci of transformed cells were counted with a microscope. The helper virus was titrated on Mus dunni cells by the fluorescence immunoassay (43) . Viral titers from NIH 3T3 cells were 2 ϫ 10 5 FFU/ml for the defective virus and 4 ϫ 10 5 FFU/ml for the helper virus. Cell supernatant containing F-MuLV 57 alone (10 6 FFU/ml) was used as a control for in vivo studies. In order to isolate viruses from leukemic tissues, organs were cut into small pieces under sterile conditions in culture medium. The supernatant was then harvested and used to infect NIH 3T3 cells. Viral titers were performed as described above. For Hirt analysis (17) , NIH 3T3 cells were infected with undiluted viral supernatants. Forty-eight hours later, the cells were lysed and the nonchromosomal DNA was collected, hydrolyzed, and analyzed by the Southern blot method.
FDCP1 cell infection. Murine myeloid IL-3-dependent FDCP1 cells were infected by cocultivation for 24 h with irradiated virus-producing NIH 3T3 cells in the presence of WEHI 3B cell conditioned medium as a source of IL-3. After infection, the FDCP1 cells were removed from the adherent cells and washed in phosphate-buffered saline (PBS) to remove surface-bound growth factors. A total of 10 5 cells were plated in T25 flasks containing Dulbecco modified Eagle medium without IL-3.
In vivo experiments. Newborn DBA/2J mice (less than 48 h old) from our own mouse colony were inoculated intraperitoneally with 0.1 ml of undiluted viral preparations. Mice were regularly examined for the development of splenomegaly by palpation under anesthesia. All severely ill mice were sacrificed for further analysis. The affected organs from leukemic animals were removed under sterile conditions, cut into small pieces, and either injected intraperitoneally or subcutaneously to nonirradiated syngeneic mice or frozen for further studies.
Southern blots. High-molecular-weight DNA isolated from tumors or from infected NIH 3T3 cells was analyzed with the following probes. The c-fms probe was a 3-kb EcoRI-NdeI fragment of the c-fms F6 clone. The VL30 probe was a 0.5-kb SacI fragment of pHFJu located upstream of the fms sequence (see Fig.  2 ). To analyze the phenotypes of the leukemias, we used the following probes: a 2.2-kb EcoRI fragment of pUC1␤ and a 2-kb EcoRI fragment of pUCJ2␤ from the T-cell receptor ␤-chain gene (23), a 1.9-kb HindIII-XbaI fragment of pECK0561 from the J segment of the heavy-chain locus (38) , and a 2-kb EcoRIBamHI fragment of p5JM from the constant segment of the kappa light chain (27) . fms protein analysis. Infected NIH 3T3 cell monolayers were washed twice with cold PBS and harvested with a cell scraper in 1 ml of PBS containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and 100 M orthovanadate. Total-cell lysates were obtained by boiling cells for 10 min in sodium dodecyl sulfate (SDS) lysis buffer (125 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol), in the presence of 10% ␤-mercaptoethanol. Aliquots (10 6 cells) were subjected to electrophoresis on SDS-7.5% polyacrylamide gels and transferred onto a nitrocellulose filter (BA-85; Schleicher & Schuell) with a high-intensity field electrotransfer apparatus (Bio-Rad). Nitrocellulose filters were blocked by an overnight incubation at 4ЊC with Tris-buffered saline (TBS)-Tween (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.1% Tween 20) containing 5% nonfat powdered milk. Filters were sequentially incubated with the rabbit polyclonal anti-mouse c-fms antibody 4599B (1/300) (13) , kindly provided by L. R. Rohrschneider, and with peroxidasecoupled donkey anti-rabbit immunoglobulin G antibody (Amersham Corp.) (1/ 10,000) enhanced and intensively washed in TBS-Tween before detection with the antibody chemiluminescence ECL kit (Amersham Corp.).
For antiphosphotyrosine immunoblotting, NIH 3T3 cells were washed twice with cold PBS and lysed in 100-mm-diameter dishes in 1 ml of RIPA buffer (0.15 M NaCl, 0.05 M phosphate [pH 7.2], 1% deoxycholate, 1% Triton X-100, 0.1% SDS) containing 1 mM PMSF, 1 mM orthovanadate, 1 mM leupeptin, 1 mM aprotinin, and 1 mM pepstatin. Lysates were then harvested, kept on ice for 20 min, disrupted by repeated aspiration through a 21-gauge needle, and centrifuged at 20,000 ϫ g for 20 min. The supernatants (5 ϫ 10 6 cells per point) were precleared by preincubation for 1 h at 4ЊC with protein A-Sepharose beads (Pharmacia) and then incubated overnight at 4ЊC with 2 l of the anti-mouse c-fms antibody. The immunoprecipitates were intensively washed before resuspension in SDS lysis buffer and solubilized by boiling for 10 min. Samples were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to nitrocellulose filters which were hybridized with a monoclonal antiphosphotyrosine antibody (4G10; Upstate Biotechnology, Inc.) (1/20,000).
To determine the cellular localization of two fms truncated proteins (N3 and N10 proteins), a membrane preparation was separated from the cytoplasmic fraction by subcellular fractionation. A total of 10 7 cells were washed twice with PBS and harvested with a cell scraper in 1 ml of buffer A (10 mM Tris-HCl [pH 7.4], 10 mM KCl, 5 mM EDTA) containing 1 mM PMSF, 1 mM leupeptin, and 1 mM aprotinin. Cells were kept on ice for 20 min and broken in a Dounce homogenizer by 10 strokes of a tight-fitting pestle. Sucrose was added up to a final concentration of 0.25 M, and the preparation was centrifuged for 15 min at 2,500 ϫ g. The supernatant was centrifuged at 45,000 ϫ g for 30 min. The 45,000 ϫ g pellet was resuspended in SDS lysis buffer in the presence of 10% ␤-mercaptoethanol and boiled for 10 min. 10ϫ SDS lysis buffer was added to the supernatant, which was boiled for 10 min. Both fractions were subjected to SDS-PAGE and electrotransferred to nitrocellulose filters which were hybridized with the anti-mouse c-fms antibody.
RT-PCR cloning and sequencing. RNA of infected NIH 3T3 cells was isolated by the method of Chomczynski and Sacchi (6), and 500 ng was subjected to reverse transcription (RT) in a final volume of 20 l. The resulting cDNAs were amplified by PCR. The 100-l PCR mixture contained 100 ng of each primer, 5 l of the RT product, 0.2 mM deoxynucleoside triphosphate, and 2 U of Taq polymerase (Perkin-Elmer Cetus). Each cDNA segment was amplified in two independent reactions in order to resolve possible nucleotide misincorporation during the PCR. The resulting PCR fragments (two for each cDNA) were cut with EcoRI and KpnI and ligated to similarly digested pBluescript KSϩ vector. The provirus N3 fragment, which had suffered the largest deletion, was digested with EcoRI and BglII and cloned at the EcoRI and BamHI sites of pBluescript KSϩ vector. DNA sequencing was determined by the Sanger method with the T7 Sequencing kit (Pharmacia).
Oligonucleotides used for PCR were as follows: two 5Ј primers, primers A (5Ј-GGAATTCCGGTCCCCTTAACGCTTAGTG-3Ј) and B (5Ј-AGCCCCTG TAGAAGCGATGA-3Ј), and two 3Ј primers, primers C (5Ј-ACTCCATCCAT GTCACGCTG-3Ј) and D (5Ј-CACACATCACTCTGAACTGTGTA-3Ј). The nucleotides in boldface type specify the EcoRI restriction site. After a precycle composed of denaturation for 2 min at 96ЊC, annealing for 2 min at 57ЊC, and synthesis for 1 min at 72ЊC, each of the 30 PCR cycles was composed of denaturation for 20 s at 96ЊC, annealing for 20 s at 57ЊC, and synthesis for 1 min at 72ЊC.
Sequencing of the remaining sequence of the cDNA (i.e., downstream of the 3Ј primers used for localization of the deletion junctions up to the end of the coding sequence) was done by RT-PCR and direct sequencing.
RESULTS

Analysis of the leukemias obtained with the c-fms-containing virus HFfms(F-MuLV).
Previous studies indicated that when inoculated into newborn DBA/2 mice, F-MuLV induced long-latency leukemias of different hematopoietic lineages (42, 54) . In this study, 40 newborn mice were inoculated with a c-fms-containing defective virus (hereafter referred to as HFfms) pseudotyped with F-MuLV [HFfms(F-MuLV)]. FMuLV alone was inoculated into 11 newborn mice as a control for the pathogenicity of the helper virus. Mice were routinely examined until the last mice died 336 days after infection with 
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HFfms(F-MuLV) and 515 days after infection with F-MuLV. The first leukemia occurred 55 days after inoculation with HFfms(F-MuLV) and 199 days after F-MuLV infection. Animals inoculated with either HFfms(F-MuLV) or F-MuLV developed splenomegaly, hepatomegaly, usually lymphadenopathies, and reduced hematocrits. A few mice developed thymomas. However, the latency of the disease was strikingly different among the two series, since 50% of mice were leukemic or had died within 165 days after inoculation with HFfms(F-MuLV) and within 358 days after inoculation with F-MuLV. These results are reported in Fig. 1 . Histological examination of enlarged organs and blood smears indicated that the diseases caused by HFfms(F-MuLV) (33 mice analyzed) and F-MuLV (8 mice) were similar. Affected organs and blood were infiltrated by dense sheets of immature and differentiated cells which belonged to the erythroid, myeloid, and lymphoid lineages with or without the predominance of one lineage. No increase in cells of the macrophage lineage was ever observed in the HFfms(F-MuLV)-induced tumors compared with F-MuLV-induced tumors. Leukemic organs from 19 HFfms(F-MuLV)-inoculated mice and from 4 F-MuLV-inoculated mice were transplanted into syngeneic mice. One to four weeks after transplantation, all the recipients exhibited hepatosplenomegaly and their peritoneal cavities were invaded by proliferating and differentiating hematopoietic cells when injected intraperitoneally, while a tumor filled with an homogenous population of undifferentiated blastic cells was observed in addition to splenomegaly after subcutaneous inoculation. For most of the transplanted tumors, the mixed phenotype consisting of the proliferation of several hematopoietic cell lineages was maintained throughout the transplantations. In some cases, however, the phenotype of the predominant lineage was different from that seen in the primary leukemia and varied throughout serial transplantations from myelocytic to lymphoid and back to mixed proliferation.
To analyze the clonality of the HFfms(F-MuLV)-induced tumors, high-molecular-weight DNA from all primary tumors was analyzed by Southern blotting. After hybridization with a fms probe, a HindIII digestion of tumor DNA generates two proviral fragments in addition to the endogenous c-fms-hybridizing fragments: a predicted 2.1-kb internal fragment and a fragment whose size would depend on the recognition of a HindIII site in host cellular sequences flanking the 5Ј end of the provirus ( Fig. 2A) . Besides the 2.1-kb fragment, HindIIIdigested DNAs of primary tumors displayed a restricted number of variable-sized fragments, which indicated the clonal or oligoclonal nature of the disease (for example, see the N12 primary tumor in Fig. 3A, lane 2) . Moreover, when this analysis was performed on DNA of transplantation series of five different tumors, the retroviral pattern was maintained throughout the transplantations, with occasionally the addition or disappearance of provirus-cell junction fragments, as illustrated in Fig. 3A , lanes 2 to 4. We could not detect any c-fms-containing provirus in two mice. These latter two were the only mice with thymomas. Southern blot analysis using TcR probes confirmed the T-lymphoid origin of these tumors (data not shown). 
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Molecular analysis of the proviruses in the leukemic cells. The integrity of the c-fms-containing proviruses was analyzed by Southern blotting with the EcoRV enzyme and the fms probe (Fig. 2) . EcoRV sites are present in the 5Ј and 3Ј proviral long terminal repeats and once in the c-fms sequence, generating 5Ј 2.6-kb and 3Ј 4.9-kb fragments. This analysis was performed on DNA of leukemic cells from all primary recipient mice. While 12 mice exhibited a provirus of the parental size (Fig. 3B, lane 2) , 20 mice exhibited rearranged proviruses alone (Fig. 3B, lanes 3 to 9) or in addition to parental-sized proviruses.
These rearranged proviruses fell into two types, as illustrated in Fig. 3B . Either the 3Ј 4.9-kb fragment generated with the EcoRV enzyme was present and the 5Ј 2.6-kb fragment was replaced by a shorter fragment (Fig. 3B, lanes 6 to 9) , or a single fragment of 6.5 kb (Fig. 3B, lanes 3 to 5) was detected. We concluded from these data and from analysis done with HindIII and SacI restriction enzymes (data not shown) that all rearranged proviruses were smaller than the parental vector provirus because of deletions in the 5Ј part of the c-fms gene and that deletions were located in the extracellular domain of the receptor. Therefore, we wondered whether the fms products encoded by rearranged proviruses would still be able to transduce a proliferative signal in NIH 3T3 cells.
Transforming potentials of viruses with deletions and analysis of the c-fms-related proteins. It has been reported that introduction of constitutively activated forms of the v-fms oncogene as well as the normal murine c-fms proto-oncogene transforms murine fibroblasts and that, in the latter case, transformation results from the activation of the murine receptor by an autocrine mechanism (34) . The transforming potentials of the viruses produced by eight tumors bearing only proviruses with deletions (N3, N10, N15, N18, N19, N20, N24, and N40) were tested. NIH 3T3 cells were infected with dilutions of supernatant prepared from these eight tumors and from one tumor in which no c-fms provirus was detected (N6). Southern blot analysis with EcoRV enzyme and the fms probe showed the same pattern of hybridization in infected NIH 3T3 cells and in the corresponding primary tumor DNA (data not shown). Transformation foci were obtained with the eight viral isolates with deletions, whereas the N6 supernatant was not transforming. These results indicated that, like the parental HFfms(F-MuLV) virus, viruses with deletions were able to transform NIH 3T3 cells. Furthermore, infection of the early myeloid IL-3-dependent FDCP1 cell line with three viruses with deletions allowed them to grow in liquid culture medium in the absence of IL-3, while FDCP1 cells infected with HFfms(F-MuLV) remained growth factor dependent (data not shown).
We analyzed the fms-related proteins encoded by the viruses with deletions in infected NIH 3T3 cells. Immunoblotting was performed with an anti-fms antibody on total lysates of infected NIH 3T3 cells. In NIH 3T3 cells infected with HFfms(FMuLV), we could detect two c-fms gene products of 165 and 140 kDa, described as the mature cell surface form and the immature form of the M-CSFR, respectively (26) . In cells infected with rearranged viruses, no normal-size c-fms product was detected, but instead shorter fms proteins, whose sizes varied according to the viral isolates, were detected, as illustrated in Fig. 4A . We detected a major protein of approximately 80 kDa in the N10, N15, and N18 virus-infected cells (lanes 3 to 5). We detected a major product of approximately 90 kDa with additional forms of 80 and 100 kDa in the N40-infected cells (lane 6), and we detected a very short protein of approximately 50 kDa in the N3-infected cells (lane 2). Lysates of infected NIH 3T3 cells were immunoprecipitated with an anti-mouse c-fms antibody and phosphotyrosine-containing proteins were detected by immunoblotting with an antiphosphotyrosine antibody. As shown in Fig. 4B , the two parental c-fms gene products as well as the truncated proteins were revealed by this antibody. These results indicated that receptors with major deletions in their extracellular domain were able to transduce a mitogenic signal in NIH 3T3 cells and to autophosphorylate.
To determine whether these shorter proteins were associated with the membranes or with the cytoplasm (see below), we enriched cell lysates of NIH 3T3 infected with N3 or N10 virus for membrane and cytosolic fractions. Results obtained after immunoblotting with an anti-mouse c-fms antibody 
3600
clearly indicated the presence of both truncated proteins in the membrane fraction (Fig. 4C ).
Cloning and sequencing of the proviruses with deletions. In order to determine the endpoints of the deletions, viral DNA from NIH 3T3 cells infected with viruses with deletions was isolated by the Hirt method. Southern blots were performed with six restriction enzymes and two probes (the fms probe and the VL30 probe derived from the Harvey sarcoma virus vector [ Fig. 2]) . The restriction maps confirmed the localization of the deletions in the c-fms extracellular domain, whereas the transmembrane and cytoplasmic regions seemed to be intact (data not shown). Two 5Ј primers (A and B) and two 3Ј primers (C and D) (Fig. 2) were chosen to perform RT-PCRs on RNA from NIH 3T3 cells infected with seven different viruses with deletions. The amplified fragments were cloned and sequenced. As represented in Fig. 5 , the seven deletions were different in size, ranging from 1 to 1.3 kb, except for the N3 deletion that extended over 2 kb. The sizes of the deletions were consistent with the restriction maps obtained by Southern blot and Hirt analyses. The sequences of the deletion junctions indicated that rearrangements resulted simply from internal deletions and that no helper virus or cellular sequences were inserted. Moreover, short regions of sequence identity surrounded the deletion junctions (Fig. 6 ). For four proviruses (N3, N10, N19, and N40), direct repeats were found at the ends of the deletion fragments. We divided proviruses with deletions into two groups on the basis of the position of the deletion 5Ј endpoint relative to the fms sequence. For the three viruses of group A (N18, N19, and N24), the deletion occurred within the c-fms sequences, downstream from the signal sequence, and did not change the open reading frame. The c-fms amino acid (aa) 104 was joined to 440 for N18, aa 47 to 411 for N19, and aa 44 to 396 for N24. For the N3, N10, N15, and N40 viruses (group B viruses), the deletion 5Ј endpoint was located within the VL30 sequences and the 3Ј endpoint was located within the c-fms gene. For three viruses of this group (N10, N15, and N40), the first nucleotide of the fms sequence was located in the fms extracellular domain and was nucleotide (nt) 1097 (codon 342) for N10, nt 965 (codon 297) for N15, and nt 929 (codon 286) for N40. For these three sequences, no inframe ATG or CTG codon was found in the 5Ј VL30 sequences, and it therefore seems likely that translation initiated at an ATG codon within the c-fms sequence. For the last virus of this group, the N3 virus, which encodes the smallest c-fmsrelated product (50 kDa; see above), the deletion joined the VL30 sequences to c-fms nt 1603 located 4 nt upstream of the c-fms transmembrane region (Fig. 7 ). An ATG codon in frame with the fms sequences was found within the VL30 sequence 60 nt upstream of the fms deletion endpoint. If this ATG codon were used for translation initiation, 20 aa encoded by the VL30 sequences would be joined to the c-fms transmembrane region in N3.
The v-fms oncogene product encoded by Suzan McDonough feline sarcoma virus differs from the c-fms feline protein by eight scattered single-amino-acid substitutions (10, 45, 56) . In addition, 14 unrelated residues are substituted for the 50 carboxy-terminal aa of the fms protein, removing a C-terminal tyrosine (Tyr-969 in the cat sequence) whose phosphorylation might negatively regulate the receptor kinase activity (45, 56) . (1), membrane-spanning region (), kinase domains (2). The lower portion of the figure shows the structure of the HFfms provirus (as shown in Fig. 2 ) and the locations of the deletions. In group A proviruses (N18, N19, and N24), the deletion is located in the c-fms sequences, while the 5Ј deletion endpoint is located upstream of the c-fms sequences in group B proviruses. 
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In order to detect eventual additional c-fms sequence alterations, we sequenced the seven proviruses downstream from the 3Ј primer up to the end of the coding sequence. No Cterminal modification was detected in five of seven proviruses.
DISCUSSION
In this study, we analyzed the in vivo effects of a retrovirus carrying the murine M-CSFR (HFfms), pseudotyped with a F-MuLV helper virus, and inoculated into newborn DBA/2 mice. These mice developed oligoclonal or monoclonal leukemias that appeared with a much shorter latency than those observed in mice inoculated with the helper virus alone.
Unexpectedly, we found that in a large number of primary leukemias, the c-fms-containing proviruses had suffered deletions in the 5Ј part of the c-fms gene, corresponding to the c-fms extracellular domain. This domain is organized in five immunoglobulin-like subdomains (40) . The first two N-terminal immunoglobulin-like regions do not directly interact with the growth factor, but in combination with the third one they constitute the high-affinity binding site for M-CSF (53) . Sequence analysis of seven proviruses with deletions revealed that in each case, the deletions removed the c-fms ligand binding domain. However, viruses with deletions isolated from tumors were able to transmit a proliferative signal in NIH 3T3 cells, which became transformed after in vitro infection. The proteins resulting from expression of the viruses with deletions still had phosphorylated tyrosines. Moreover, FDCP1 cells infected with viruses with deletions were able to grow in the absence of IL-3. These results indicated that the c-fms-containing proviruses with deletions encoded constitutively activated forms of the M-CSFR. Rearranged proviruses had deletions either within the fms gene-downstream of the c-fms signal peptide, resulting in a truncated c-fms gene with an unchanged open reading frame (group A viruses)-or spanning a viral region containing the VL30 sequences and the N-terminal portion of the fms extracellular domain (group B viruses). In three proviruses of this group (N10, N15, and N40), no ATG or CTG codon was present upstream of the deletion junctions in the potential reading frame of the VL30 sequences. The corresponding fms-related proteins were most likely translated from one of the several ATG codons present in the fms sequences between the deletion junction and the transmembrane domain. The resulting sequence no longer contains a class I potential signal peptide, only a transmembrane region. In the group B provirus with the largest deletion (N3), the deletion junction was located immediately upstream of the fms transmembrane domain, which contains two ATG codons (Fig. 5B) . The use of either one of these codons would result in a protein with a much shorter transmembrane region (12 or 15 aa instead of 26). Interestingly, there was an ATG codon in frame with the c-fms sequence within the VL30 region, 20 aa upstream of the 3Ј deletion endpoint. The protein resulting from the use of this initiating codon would have an intact transmembrane region. Subcellular localization studies performed on NIH 3T3 cells infected with two group B viruses (N10 and N3) indicated that in each case, c-fms-related products were associated with the cellular membrane fraction. Sequence analysis of the proviruses with deletions revealed that the transmembrane domain was always present. The group B viruses we describe are reminiscent of the oncogenic form of another tyrosine kinase receptor, the epidermal growth factor receptor, transduced in the avian erythroblastosis virus. In fact, most of the epidermal growth factor receptor extracellular domain, including its signal peptide, is deleted in the v-erbB protein and is fused to the first 6 aa of the gag gene (11) . However, a fraction of this protein, associated with the transforming activity, is found inserted in the plasma membrane (2, 37) . It is also known that some cellular proteins devoid of canonical signal sequences are directed to the plasma membrane through an internal membrane-spanning region (47) .
Comparison of the v-fms sequence transduced in the Suzan McDonough feline sarcoma virus strain with those of the feline c-fms gene reveals that v-fms has suffered (i) a small deletion resulting in the loss of the c-fms 50 carboxy-terminal aa and (ii) point mutations resulting in eight amino acid substitutions scattered along the protein sequence. Although the v-fms-encoded glycoprotein can act as a ligand-independent tyrosine kinase, the v-fms extracellular domain still binds M-CSF (for a review, see reference 40). Moreover, it has been shown that generation of a fully transforming c-fms gene requires mutations in both the extracellular and C-terminal domains (35, 56) and that the C-terminal truncation is necessary to the dimerization of fms mutants in the absence of M-CSF (3). In this study, five of seven viruses did not present any alteration of the c-fms C-terminal sequence. This result supports the idea that conformational modifications resulting from deletions of the fms extracellular domain can result in constitutive activation in the absence of a C-terminal truncation or mutation.
A short region of sequence identity was found just upstream from the deletion endpoints in four proviruses with deletions, while stretches of homologous sequences were located around the deletion junctions in three other proviral mutants. This result suggests that the deletions were likely to occur through misalignments of repeated sequences during viral replication. It is noticeable that no F-MuLV gag or env sequence was found inserted at the deletion junctions. Unlike other oncogenic forms of tyrosine kinase receptor transduced by retroviruses, the constitutively activated forms of the c-fms we describe result simply from deletions. This could be explained by the structure of the VL30 packaging signal which is responsible for the formation of stable homodimeric RNA (49) and by the absence of homology between the coding sequences of F-MuLV and VL30 sequences. The genetic instability occurring during replication of retroviral vectors might be influenced by the genetic variation in the course of infection and by the selective advantage conferred by viral mutants. In fact, proviral deletions observed during replication of retroviruses in the absence of selection pressure usually lead to inactivation of reporter genes (30, 51) . Since HFfms proviruses with dele- 
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tions were observed with a high frequency (more than 50% of primary tumors) and since all forms with deletions consisted of constitutively activated forms of the M-CSFR, it is most likely that infected cells expressing activated receptor forms acquired a proliferative advantage. One may then wonder whether the normal-sized HFfms proviral forms observed in 50% of the primary tumors would have gained activating point mutations or subtle modifications not detectable by Southern blot analysis. To answer this question, viruses from four primary tumors with normal-sized HFfms proviruses were used to infect the IL3-dependent FDCP1 cell line in vitro. All viruses were able to confer growth factor independence to this cell line (data not shown), suggesting that constitutively activated forms of the c-fms gene had indeed been generated in vivo, either by mutation or by deletion. One can suppose that in an initial step, proliferation of hematopoietic cells expressing the normal cfms gene was stimulated by the M-CSF produced by the bone marrow stroma, but that in a second step, independent cells containing a constitutively activated form of the M-CSFR had a growth selective advantage. Therefore, the latency of the disease induced by HFfms may be influenced by the time of generation and selection of viral mutants, but additional events, such as insertional mutagenesis, probably cooperate with the fms proliferative signal to result in the appearance of clonal and transplantable hematopoietic tumors. Histological analysis of the leukemia showed that the types of diseases induced by the Jules (F-MuLV) virus were similar to those induced by F-MuLV, i.e., proliferative syndromes involving the erythroid, myeloid, and lymphoid lineages, with occasionally predominance of a single lineage. Primary tumors were clonal or oligoclonal, while transplanted tumors were monoclonal and often exhibited mixed hematopoietic populations, suggesting that they originated from a pluripotent progenitor cell. Thus, our results support the idea that expression of the lineage-specific M-CSFR in pluripotent hematopoietic cells does not trigger differentiation into the monocytic lineage. This is consistent with the in vitro results of other groups, which introduced the M-CSFR gene in immature pluripotent progenitors (28, 31) and did not observe any differentiation under M-CSF stimulation.
Previous studies suggested that M-CSFR can transmit a proliferative signal in a wide range of hematopoietic cells. This was demonstrated in vitro after ectopic expression of M-CSFR in immature myeloid cells (19-21, 32, 33, 52) , murine fetal liver cells (28) , or immature murine spleen colonies (31) , and in vivo with a v-fms-containing virus (15) . In fact, the only lineage in which M-CSFR may not function seems to be the T-lymphoid lineage (36, 52) . In this study, 2 of 33 mice inoculated with Jules (F-MuLV) virus did not contain the Jules provirus. These two mice, and only these two, had thymomas, and Southern blot analysis with TcR probes confirmed the T cellular origin of this proliferation. Therefore, it seems likely that the T lymphomas we observed were induced by the helper virus. However, the fact that these two mice died earlier than the mice inoculated with F-MuLV alone suggests an indirect involvement of the c-fms gene in the occurrence of these two tumors.
